Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revamilast in active rheumatoid arthritis
NCT01430507Phase 2Completed
- Sponsor
- Glenmark Pharmaceuticals
- Start
- Sep 2011
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of revamilast in rheumatoid arthritis (RA), sponsored by Glenmark Pharmaceuticals. Started Sep 2011; status: completed.
02
Drugs
revamilast
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01430507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01430507.